Clinician-Reviewed Test Set Construction
Assembling representative cases with expected outputs reviewed by qualified clinicians, including edge cases and the failure modes the capability is most likely to produce.
Healthcare AI evaluation engineers build the measurement infrastructure that establishes whether AI output is good enough to deploy and still good enough to keep running. They construct clinician-reviewed test sets, automated scoring, subgroup analysis, and regression detection, so quality claims rest on evidence rather than on demonstration.
Evaluation is the capability most healthcare AI programs lack and the one governance committees ask about first. Without it, nobody can say whether a change improved anything, whether performance differs across populations, or whether the system still works. Every other AI investment depends on this one. Taction Software builds it first, and our hire dedicated developers hub covers implementation roles.

Our experts are ready to understand your business goals.






























































Evaluation infrastructure is a product with users: the engineers who need regression signals, the clinical reviewers who supply judgment, and the governance committee that requires evidence. The work below reflects that. Test set construction appears first because it is the expensive foundation, and because a test set built without clinical review produces measurement that looks rigorous and means little.
Assembling representative cases with expected outputs reviewed by qualified clinicians, including edge cases and the failure modes the capability is most likely to produce.
Implementing scoring for grounding, omission, format compliance, and constraint adherence so a full test suite runs on every change rather than being sampled manually.
Measuring output quality across populations including race, language, age, sex, and insurance status, with results reported rather than aggregated away.
Running evaluation in the deployment pipeline so a change that degrades quality is caught before release rather than after a clinician notices.
Sampling live output for periodic clinical review, since offline test sets diverge from production distribution as populations and documentation practice change.
Producing the documentation review committees require, covering methodology, results by subgroup, known limitations, and monitoring arrangements.
Evaluating clinical AI requires clinical judgment, which makes reviewer time the binding constraint rather than engineering capacity. It also requires measuring the right thing: omission rather than fluency, subgroup performance rather than averages, and clinical consequence rather than similarity to a reference. The context below spans the healthcare work you assign and determines whether evaluation means anything.
Test sets need clinician-established expected outputs. Engineering can build infrastructure quickly and cannot substitute for the clinical judgment that gives it meaning.
For generated clinical content, missing information is more dangerous than awkward phrasing. Scoring must target omission specifically rather than measuring similarity to a reference.
A single quality figure hides uneven performance across populations. Subgroup reporting is a requirement rather than an additional analysis to perform if time permits.
Offline sets age as populations and documentation change. Production sampling with periodic clinical review is required to detect that divergence.
Clinicians disagree on many judgments. Agreement should be measured, since reported performance cannot exceed the reliability of the reference itself.
Passing evaluation means output met measured criteria. It does not establish clinical safety, which remains an organizational determination involving human review and monitoring.
This is measurement engineering with unusual dependence on domain input. The specialist skills are designing scoring that captures clinically meaningful quality and building infrastructure clinical reviewers will actually use. The competencies below reflect that. Weight scoring design and reviewer tooling above pipeline engineering, since infrastructure that clinicians will not engage with produces no reference data.
Constructing representative sets covering normal, edge, and adversarial cases with sampling that reflects production distribution rather than convenient examples.
Building annotation and review environments clinicians can use efficiently, with guidelines and adjudication for disagreement and agreement measurement built in.
Implementing grounding checks, omission detection, format validation, and where appropriate model-based scoring with its own validation against clinical judgment.
Computing and presenting performance by population with sufficient sample sizes, and identifying where sample size prevents reliable subgroup conclusions.
Running evaluation on every change with clear pass criteria. Our healthcare integration work covers connectivity where evaluation touches clinical systems.
Capturing and routing live output for review with appropriate PHI handling, so ongoing assessment does not create an unmanaged clinical content store.
The distinguishing question is who established the expected outputs. Engineers who built test sets with clinical review produced meaningful measurement; those who wrote references themselves measured agreement with an engineer’s opinion. Our assessment centers on test set provenance, scoring design, and subgroup practice. Our delivery process includes review points for reassessing fit.
We ask who established expected outputs. Engineer-written references measure agreement with engineering judgment rather than clinical adequacy.
We ask how they scored missing information. Similarity-based scoring rewards fluent output that omits critical content, which is the failure mode that matters.
We ask what they found across populations. Engineers reporting only aggregate figures have not treated disparity as something evaluation must surface.
We ask how clinicians used their tooling. Review environments clinicians avoid produce no reference data regardless of how well the scoring is engineered.
We ask what inter-reviewer agreement they observed. Unmeasured agreement means the reference reliability, and therefore the meaning of reported scores, is unknown.
We describe which evaluation infrastructure each engineer built and what it governed. We do not claim clinical credentials for engineers who lack them.
Evaluation should be built before or alongside the capability it measures, because retrofitting it means running unmeasured in the interim and losing the baseline against which change would be assessed. Structures below reflect that. We recommend evaluation-first engagements more often than clients expect, since they frequently establish that a use case is not viable.
Building measurement before the capability. This establishes whether the use case can meet a quality bar and regularly ends projects before larger investment.
Where a capability is being built, evaluation designed alongside it establishes a baseline from launch and makes every subsequent change assessable.
Where AI is running without measurement, building evaluation for it has clear value and is frequently what a governance committee has already asked for.
Where you own evaluation practice, staff augmentation adds measurement engineering within your existing standards and reviewer arrangements.
A dedicated healthcare development team treats evaluation as shared infrastructure across AI capabilities rather than as per-project work.
Where the capability and quality criteria are defined, a fixed-scope engagement under our engagement models delivers test sets, scoring, and reporting.
Share your deployed or planned AI capabilities and how quality is currently assessed. If the answer is manual spot checks, evaluation infrastructure is the gap.
Evaluation establishes measured quality against defined criteria and nothing beyond that. We build to HIPAA-aligned practices where HIPAA applies; software cannot be HIPAA certified. Where intended use may create diagnostic or treatment claims, SaMD classification is assessed during discovery. Passing evaluation does not establish clinical safety or regulatory compliance.
Expected outputs come from qualified clinicians. Engineering builds infrastructure and scoring; it does not determine what constitutes clinically adequate output.
Performance by population is presented alongside overall figures, since a single number conceals the disparity evaluation exists partly to detect.
Every evaluation states what was measured, on what distribution, with what sample sizes, and what conclusions the data cannot support.
Live output captured for review is handled under clinical data controls, since sampling infrastructure otherwise becomes an unmanaged store of patient content.
Capabilities touching behavioral health require careful review arrangements. We built CHIPSS, a behavioral health system, where content handling was tightly governed.
We would not report evaluation results as evidence of clinical safety, present aggregate figures without subgroup analysis, or describe engineer-written references as clinical validation.
Cost concentrates in test set construction and clinical reviewer time rather than in scoring infrastructure. Reviewer availability from your side is the substantial input and frequently sets the timeline. We publish no figures on quality improvement, because evaluation measures rather than improves. What we deliver is measurement your engineering team and governance committee can both act on.
$40,000 to $80,000
Evaluation for one AI capability with test set construction, reviewer tooling, automated scoring, subgroup analysis, pipeline gating, and governance reporting.
$80,000 to $200,000
Shared evaluation infrastructure across AI capabilities with common scoring, reviewer workflow, production sampling, regression gating, and portfolio-level reporting.
Starting at $200,000
Multi-facility evaluation with population variation, governance frameworks, validation documentation, and reporting across several clinical environments and capabilities.
Discovery is paid and time-boxed. It produces a current measurement assessment, quality criteria definition with clinical input, reviewer capacity analysis, and an itemized fixed-scope estimate.
Capability count, test set size and complexity, clinical reviewer availability, scoring sophistication required, subgroup analysis scope, production sampling volume, and governance documentation depth.
Test sets age and production distributions shift. Budget for periodic test set refresh, reviewer cycles, scoring maintenance, and production sampling review on a continuing basis.
Third-party licensing, cloud infrastructure, data subscriptions, and hardware are separate from engineering cost and itemised clearly.
Two questions matter. Whether the vendor requires clinical review for reference outputs, and whether they build evaluation before capabilities. Taction Software has built healthcare software since 2013, more than twelve years, with over 200 healthcare projects delivered and ISO 27001 certification. Leadership brings more than twenty years of personal experience in the field, which is separate from company age. Our wider case for Taction sits elsewhere.
We built Voyant Health, an EHR platform. Our healthcare case studies reflect knowledge of what clinically adequate output looks like in real workflows.
We built Revive Ease and PainKare, both FDA-registered applications. That work informs how we document evaluation methodology and limitations for review.
We built CHIPSS, a behavioral health system, where content handling was tightly governed. Evaluation involving such content requires equivalent restraint.
Taction Software holds ISO 27001 certification covering our information security management practices. It certifies our internal processes and does not determine your organization’s compliance position.
We will not build test sets with engineer-written expected outputs. That requirement depends on your clinician availability and occasionally delays engagements substantially.
Measuring before building regularly establishes that a use case cannot meet a quality bar. That conclusion ends the engagement and is the correct outcome.
We review your capabilities, current quality assessment, and clinical reviewer availability, then present candidates with evaluation infrastructure experience. You interview and approve each engineer.
Evaluation for one capability runs $40,000 to $80,000, shared infrastructure $80,000 to $200,000, and enterprise programs start at $200,000. Cloud and inference costs are itemized separately.
Our delivery history includes the Voyant Health EHR platform, the CHIPSS behavioral health system, and the FDA-registered applications Revive Ease and PainKare, within more than 200 healthcare projects delivered since 2013.
Because expected outputs define what counts as adequate, which is a clinical judgment. Engineer-written references measure agreement with engineering opinion rather than clinical adequacy.
No. It means output met measured criteria on a defined distribution. Clinical safety involves human review, monitoring, and organizational determination beyond what evaluation establishes.
Evaluation establishes quality before and at deployment against curated test sets. Observability monitors live behavior in production, including drift, cost, and clinician override rates.
Share your AI capabilities, how quality is currently measured, your clinical reviewer availability, your governance reporting requirements, and the engagement model you have in mind. We will require clinical reference outputs and say plainly if a capability cannot meet a quality bar. We do not promise instant matching or any quality figure.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.